# COVID-19 International Drug Pregnancy Registry

> **NCT05013632** · — · RECRUITING · sponsor: **Pregistry** · enrollment: 2000 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Antiviral Agents
- **DRUG:** Monoclonal antibody

## Key facts

- **NCT ID:** NCT05013632
- **Lead sponsor:** Pregistry
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-01
- **Primary completion:** 2027-09-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2025-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05013632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05013632, "COVID-19 International Drug Pregnancy Registry". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05013632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*